i
July 1, 2022

ClotChip Real-Time Coagulation Testing, Masimo Continuous RRp Monitoring & Abbott’s Freestyle Libre 2 Advanced Wearable Glucometer FDA Cleared

at July 1, 2022Published by FDA Updates
ClotChip allows for timely decision-making with 15-minute coagulation profiles, and Abbott's Freestyle libre 2 transfers continuous glycemia...
Do you like it?
Read more
i
August 1, 2022

FINDER, Tap blood collector and SOZO

at August 1, 2022Published by FDA Updates
Bedside G6PD Deficiency Testing to improve hyperbilirubinemia management, painless blood sampling with microneedles...
Do you like it?
Read more
i
September 1, 2022

Cognoa; Olympus’s endoscope; BioSticker

at September 1, 2022Published by FDA Updates
Cognoa aims to rule out or diagnose ASD. Olympus's endoscope spots suspicious lesions and polyps. The BioSticker prevent illness exacerbation...
Do you like it?
Read more
i
October 1, 2022

CLEW, Transenterix, and Ultrasounds.

at October 1, 2022Published by FDA Updates
CLEW predicts respiratory failure, TransEnterix enhances surgeons' performance, are cleared to diagnose cardiovascular complications...
Do you like it?
Read more
i
November 1, 2022

FDA Cleared: Strados RESP Monitors Lung Sounds; Help Spot Collapsed Lung; First Cuff-Free Blood Pressure Monitors

at November 1, 2022Published by FDA Updates
The FDA has cleared AI-based technologies, including cuff-less blood pressure monitoring and physical examination auscultation recordings...
Do you like it?
Read more
i
December 1, 2022

FDA Cleared Imbio an AI programs for scanning lung diseases; Neuromuscular Tongue Stimulator for Snoring & Vitls Platform for Remote Patient Monitoring

at December 1, 2022Published by FDA Updates
AI programs have been developed to scan lung disease, treat OSA, and perform remote patient monitoring...
Do you like it?
Read more
Prev page
123456
Next page
Contact Us